Jonas M M, Kelly F E, Linton R A, Band D M, O'Brien T K, Linton N W
Shackleton Department of Anaesthetics, Southampton General Hospital, Southampton, SO16 6YD, UK.
J Clin Monit Comput. 1999 Dec;15(7-8):525-8. doi: 10.1023/a:1009914714769.
We have previously described an indicator dilution technique of measuring cardiac output in which lithium chloride is injected as a bolus via a central venous catheter and cardiac output derived from the arterial lithium dilution curve recorded from a lithium-selective electrode, which we have developed for this purpose. It would be an advantage if the lithium could be injected via the basilic vein (in the antecubital fossa) in those patients who do not need central venous catheterisation for other reasons. We have therefore compared cardiac output measurements made using these two routes of lithium chloride administration.
Lithium dilution cardiac output was measured 10 times in each of 10 patients, injecting the lithium chloride alternately via the basilic or central venous catheter.
The mean difference was 0.8 +/- 5.2% (SD) (range -8.5 to +7.0%) over a range of cardiac output of 4.5-13 l/min.
Injection of lithium chloride via the basilic vein in the antecubital fossa allows accurate lithium dilution cardiac output measurements to be made in patients who do not have central venous catheters in place.
我们之前描述了一种测量心输出量的指示剂稀释技术,即通过中心静脉导管推注氯化锂,并根据为此目的开发的锂选择性电极记录的动脉锂稀释曲线得出心输出量。对于因其他原因无需中心静脉置管的患者,如果能通过(肘前窝的)贵要静脉注射锂,将会是一个优势。因此,我们比较了使用这两种氯化锂给药途径测量的心输出量。
对10名患者每人进行10次锂稀释心输出量测量,交替通过贵要静脉或中心静脉导管注射氯化锂。
在心输出量为4.5 - 13升/分钟的范围内,平均差异为0.8±5.2%(标准差)(范围为 - 8.5%至 + 7.0%)。
对于未留置中心静脉导管的患者,通过肘前窝的贵要静脉注射氯化锂可进行准确的锂稀释心输出量测量。